VERTEX ONE ASSET MANAGEMENT INC. - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAF1. A total of 34 filers reported holding PDL BIOPHARMA INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
VERTEX ONE ASSET MANAGEMENT INC. ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2015$886,000
-53.5%
1,000,000
-50.0%
0.12%
+8.0%
Q2 2015$1,906,000
+98.1%
2,000,000
+100.0%
0.11%
-1.8%
Q1 2015$962,000
+0.1%
1,000,0000.0%0.11%
+8.6%
Q4 2014$961,000
-1.8%
1,000,0000.0%0.10%
+6.1%
Q3 2014$979,000
-14.9%
1,000,0000.0%0.10%
-14.7%
Q2 2014$1,150,000
+8.8%
1,000,0000.0%0.12%
-7.9%
Q1 2014$1,057,0001,000,0000.13%
Other shareholders
PDL BIOPHARMA INC shareholders Q1 2015
NameSharesValueWeighting ↓
Context Capital Management, LLC 6,500,000$6,309,0006.13%
SANDERS MORRIS HARRIS LLC 79,452$14,935,0004.53%
ASCEND CAPITAL, LLC 39,840,000$38,744,0002.37%
WHITEBOX ADVISORS LLC 27,730,000$26,933,0001.12%
Kissinger Financial Services LLC 3,129,000$3,042,0001.11%
Park West Asset Management LLC 10,923,000$10,609,0000.96%
AQR Arbitrage LLC 22,225,000$21,697,0000.21%
OAKTREE CAPITAL MANAGEMENT LP 11,091,000$10,842,0000.14%
WOLVERINE ASSET MANAGEMENT LLC 8,133,000$7,899,0000.12%
ZAZOVE ASSOCIATES LLC 1,580,000$1,539,0000.07%
View complete list of PDL BIOPHARMA INC shareholders